Pancreatic Cancer Research

ResearcherGunma UniversityNo recent work listed

Hiroyuki Kuwano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1809-8483; OpenAlex author ID A5017461232. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 2 papers · 2018: 3 papers · 2019: 1 paper

Papers 7

  1. Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts. Co-author DOI 10.1111/cas.13847↗
  2. Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00280-017-3477-4↗
  3. Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer. Co-author DOI 10.18632/oncotarget.25837↗
  4. High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer. Co-author DOI 10.21873/anticanres.12307↗
  5. Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression. Last author DOI 10.18632/oncotarget.14703↗
  6. Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1. Co-author DOI 10.18632/oncotarget.22634↗
  7. Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin. Co-author DOI 10.1002/ijc.25946↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ken Shirabe · 6 shared papers, 2017–2019 · strength 0.41
  2. Kenichiro Araki · 6 shared papers, 2011–2019 · strength 0.36
  3. Mariko Tsukagoshi · 5 shared papers, 2017–2019 · strength 0.34
  4. Akira Watanabe Watanabe · 5 shared papers, 2017–2019 · strength 0.33
  5. Takehiko Yokobori · 5 shared papers, 2017–2019 · strength 0.33
  6. Norihiro Ishii · 4 shared papers, 2017–2019 · strength 0.26
  7. Takamichi Igarashi · 4 shared papers, 2017–2019 · strength 0.26
  8. Takahiro Yamanaka · 4 shared papers, 2017–2019 · strength 0.26
  9. Bolag Altan · 3 shared papers, 2017–2018 · strength 0.19
  10. Kei Hagiwara · 2 shared papers, 2018–2019 · strength 0.14
  11. Norifumi Harimoto · 2 shared papers, 2018–2019 · strength 0.14
  12. Erica Yada · 1 shared paper, 2018 · strength 0.08
  13. Satoshi Wada · 1 shared paper, 2018 · strength 0.08
  14. Tetsuro Sasada · 1 shared paper, 2018 · strength 0.08
  15. Hiroki Yamaue · 1 shared paper, 2018 · strength 0.08
  16. Seiko Hirono · 1 shared paper, 2018 · strength 0.08
  17. Atsushi Masamune · 1 shared paper, 2019 · strength 0.08
  18. Kyoichi Kaira · 1 shared paper, 2018 · strength 0.07
  19. Yoshikatsu Kanai · 1 shared paper, 2018 · strength 0.07
  20. Kazunobu Suzuki · 1 shared paper, 2018 · strength 0.07
  21. Avraham Raz · 1 shared paper, 2011 · strength 0.03
  22. Tsutomu Kobayashi · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.